Showing results (1211-1220 of 1,532) with videos related to
Sort By:
Pageof 154
Journal of Strength and Conditioning Research|February 4, 2015
Application of the Critical Heart Model to Treadmill RunningHaley C Bergstrom, Terry J Housh, Kristen C Cochrane, et al.BMJ Open|October 6, 2023
iVY: protocol for a randomised clinical trial to test the effect of a technology-based intervention to improve virological suppression among young adults with HIV in the USAParya Saberi, Marie C D Stoner, Caravella L McCuistian, et al.Journal of Nutritional Science|June 18, 2016
Circulating n-3 fatty acids and trans-fatty acids, PLA2G2A gene variation and sudden cardiac arrestRozenn N Lemaitre, Traci M Bartz, Irena B King, et al.Journal of Clinical Pharmacology|February 24, 2006
Effects of ezetimibe on cyclosporine pharmacokinetics in healthy subjectsArthur J Bergman, Joanne Burke, Patrick Larson, et al.AIDS and Behavior|June 9, 2009
Behavior change following diagnosis with acute/early HIV infection-a move to serosorting with other HIV-infected individuals. The NIMH Multisite Acute HIV Infection Study: IIIWayne T Steward, Robert H Remien, Jenny A Higgins, et al.Lancet (London, England)|March 7, 2015
Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 studyJohn J P Kastelein, Joost Besseling, Sukrut Shah, et al.The Journal of the Association of Nurses in AIDS Care : JANAC|November 13, 2019
Complexities of HIV Disclosure in Patients Newly Entering HIV Care: A Qualitative AnalysisCrystal Chapman Lambert, Will L Tarver, Pamela L Musoke, et al.Journal of Musculoskeletal & Neuronal Interactions|March 6, 2020
Neuromuscular responses of the superficial quadriceps femoris muscles: muscle specific fatigue and inter-individual variability during severe intensity treadmill runningHaley C Bergstrom, Terry J Housh, Taylor K Dinyer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid TumorsAndrew J Wagner, Udai Banerji, Amit Mahipal, et al.Neuro-Oncology Practice|August 15, 2025
Phase II randomized glioma study to evaluate efficacy and satisfaction of rolapitant plus ondansetron in preventing chemoradiation-induced nausea and vomitingMary Lou Affronti, Mallika P Patel, Erin K Severance, et al.Pageof 154